EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma

Hyung Seok Kim, Ji Yi Choi, Geum Ok Baek, Moon Gyeong Yoon, Se Ha Jang, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jee-Yeong Jeong, Jung Woo Eun

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl41684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Hyung Seok Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Kosin University College of Medicine, 49267 Busan, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Pseudogenes, Biomarkers, Tumor. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, Ministry of Science and ICT (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related mortality worldwide. Despite advances in therapeutic approaches, the lack of effective biomarkers continues to limit early detection and prognostic evaluation. Pseudogenes, once considered nonfunctional, have emerged as regulators of biological processes in tumors and as potential biomarkers. This study aimed to identify and validate BMS1 Pseudogene 8 (BMS1P8) as a liver-specific, clinically relevant diagnostic and prognostic biomarker in HCC.

Methods

A comprehensive survey of pseudogene expression across different stages of liver disease was performed and validated using clinical HCC samples. Correlation, enrichment, and competing endogenous RNA (ceRNA) analyses integrating matched microRNA (miRNA)-seq and mRNA-seq were used to explore the functional networks surrounding BMS1P8. Public RNA-seq datasets (GSE114564, The Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA_LIHC)) were used to delineate differentially expressed pseudogenes, and 98 paired tumor and non-tumor tissues were assessed using quantitative reverse transcription polymerase chain reaction. Diagnostic and prognostic performances were evaluated using receiver operating characteristic curves and Kaplan–Meier statistics.

Results

BMS1P8 was markedly upregulated in HCC and was overexpressed in 25 other cancer types. Receiver operating characteristics analysis yielded an area under the curve of 0.81, underscoring the diagnostic utility. High BMS1P8 expression and enrichment of cell cycle pathways were associated with poor survival. ceRNA screening revealed an inverse BMS1P8–miR-30c-2-3p correlation and concordant NME/NM23 nucleoside diphosphate kinase 6 (NME6) upregulation, with the BMS1P8/miR-30c-2-3p/NME6 triad further stratifying patient outcomes.

Conclusion

Our findings highlight BMS1P8 as a novel liver-specific biomarker with substantial diagnostic and prognostic value in HCC. Its diagnostic utility suggests its potential application in early detection and personalized treatment strategies, contributing to improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPseudogenesBiomarkers, TumorHumansPrognosisGene Expression Regulation, NeoplasticMaleFemaleMiddle AgedMicroRNAsKaplan-Meier EstimateROC Curve

Stichwörter der Autor:innen

biomarkersdiagnosishepatocellular carcinomaprognosispseudogene

Substanzen

Biomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Department of Biochemistry, Kosin University College of Medicine, 49267 Busan, Republic of Korea.
  • Department of Gastroenterology, Ajou University School of Medicine, 16499 Suwon, Republic of Korea.
  • Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 16499 Suwon, Republic of Korea.

Förderung

  • Ministry of Health and Welfare
  • Ministry of Science and ICT (MSIT)

Zitieren

APA

Kim, H. S., Choi, J. Y., Baek, G. O., Yoon, M. G., Jang, S. H., Han, J. E., Kim, S. S., Cheong, J. Y., Jeong, J. Y., & Eun, J. W. (2025). A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl41684

Vancouver

Kim HS, Choi JY, Baek GO, Yoon MG, Jang SH, Han JE, et al. A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl41684

BibTeX
@article{Kim2025,
  author = {Kim, Hyung Seok and Choi, Ji Yi and Baek, Geum Ok and Yoon, Moon Gyeong and Jang, Se Ha and Han, Ji Eun and Kim, Soon Sun and Cheong, Jae Youn and Jeong, Jee-Yeong and Eun, Jung Woo},
  title = {A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl41684}
}
Kostenlos starten →